PetMed Express Files 8-K on July 1, 2025

Ticker: PETS · Form: 8-K · Filed: 2025-07-01T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure, regulatory

Related Tickers: PETS

TL;DR

PETS filed an 8-K on 7/1/25 covering Reg FD, other events, and financials.

AI Summary

PetMed Express, Inc. filed an 8-K on July 1, 2025, reporting on events that occurred on the same date. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, incorporated in Florida with fiscal year end March 31, is headquartered in Delray Beach.

Why It Matters

This 8-K filing provides an update on PetMed Express's corporate activities and disclosures, which is important for investors to stay informed about the company's regulatory compliance and operational events.

Risk Assessment

Risk Level: low — This filing is a routine 8-K report and does not appear to contain any immediately alarming or significant negative news.

Key Players & Entities

FAQ

What specific events are being disclosed under 'Other Events' in this 8-K filing?

The provided text does not detail the specific events covered under 'Other Events'.

Are there any preliminary financial results or updates included in the 'Financial Statements and Exhibits' section?

The filing indicates 'Financial Statements and Exhibits' are included, but the specific content or preliminary results are not detailed in the provided text.

What is the significance of the 'Regulation FD Disclosure' item?

Regulation FD Disclosure indicates that the company is making public disclosures to ensure fair and widespread dissemination of material information.

When is PetMed Express's fiscal year end?

PetMed Express's fiscal year ends on March 31.

What is the primary business of PetMed Express, Inc. based on its SIC code?

Based on the SIC code [5912], PetMed Express, Inc. is in the 'RETAIL-DRUG STORES AND PROPRIETARY STORES' industry.

From the Filing

0001040130-25-000036.txt : 20250701 0001040130-25-000036.hdr.sgml : 20250701 20250701083712 ACCESSION NUMBER: 0001040130-25-000036 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250701 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250701 DATE AS OF CHANGE: 20250701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251094252 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20250701.htm 8-K pets-20250701 0001040130 FALSE 0001040130 2025-06-10 2025-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  July 1, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ  Global Select Market Preferred Stock Purchase Rights N/A NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 7.01. Regulation FD Disclosure. On July 1, 2025, PetMed Express, Inc. (the “Company”) issued a press release providing an update on the status of the filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “2025 Form 10-K”) and disclosing other matters set forth in Item 8.01 below. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Item 7.01 on this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabil

View on Read The Filing